Christina M. Stragliotto-Linder - Publications

Navigating the Role of Radiotherapy for Extremity Soft Tissue Sarcomas.

Journal: Biomedicines

Published: June 12, 2026

Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 11, 2025

Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 23, 2025

Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.

Journal: JCO precision oncology

Published: September 19, 2025

Oncological Outcome for 83 Consecutive Patients With Malignant Peripheral Nerve Sheath Tumors Treated at a Tertiary Referral Centre.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 27, 2025

Improved local control using higher dose SBRT in metastatic sarcoma patients.

Journal: Radiation oncology (London, England)

Published: February 27, 2025

Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 02, 2024

Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas.

Journal: Biomolecules

Published: January 04, 2022

The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center.

Journal: International journal of cancer

Published: December 14, 2021

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.

Journal: Cancer immunology, immunotherapy : CII

Published: February 23, 2020

Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden.

Journal: PloS one

Published: April 12, 2018